N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine
C22H25F2N3 — CID 144929164
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine
N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine (PubChem CID 144929164) has the molecular formula C22H25F2N3 and a molecular weight of 369.46 g/mol. Its IUPAC name is N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine.
Molecular Properties
| Compound Name | N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine |
|---|---|
| PubChem CID | 144929164 |
| Molecular Formula | C22H25F2N3 |
| Molecular Weight | 369.46 g/mol |
| Exact Mass | 369.20 |
| IUPAC Name | N-[3-[5-(3,5-difluorophenyl)-2-methylphenyl]-3-iminoprop-1-en-2-yl]-1-methylpiperidin-4-amine |
| SMILES | [H]/N=C(\C(=C)NC1CCN(C)CC1)c1cc(-c2cc(F)cc(F)c2)ccc1C |
| InChI | InChI=1S/C22H25F2N3/c1-14-4-5-16(17-10-18(23)13-19(24)11-17)12-21(14)22(25)15(2)26-20-6-8-27(3)9-7-20/h4-5,10-13,20,25-26H,2,6-9H2,1,3H3/b25-22+ |
| InChIKey | BUYGGBXXOQKTNQ-YYDJUVGSSA-N |
| XLogP | 4.51 |
| TPSA | 39.12 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 369.46 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144929164 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.